NR0B2 and metabolic dysfunction-associated steatohepatitis: Indeed, they proposed that activation of Nrf2 resulted in FXR-mediated induction of Shp, which subsequently inhibited LXRα by forming an inactive LXRα-Shp heterodimer, and prevented T0901317 from stimulating NASH.